Cumberland Pharmaceuticals Inc. CPIX stock is trading higher on Friday following positive updates from the company’s Phase 2 FIGHT DMD trial, which evaluates ifetroban for Duchenne muscular dystrophy ...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and ...

In the latest trading session, Cumberland Pharmaceuticals (CPIX) closed at $6.19, marking a -0.16% move from the previous day. This change lagged the S&P 500's 0.3% gain on the day. At the same time, ...

FDA approved a simplified Acetadote dosing regimen, reducing errors and serious reactions while maintaining effectiveness. Acetadote addresses liver injury from acetaminophen toxicity, the leading ...

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of ...

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The Nashville, Tennessee-based pharmaceutical company’s shares ended trading yesterday at $2.20. However, the stock is now up $2.02 in morning trading on news of the FDA approval. This is a welcomed ...

After returning to profitability in 2014, Cumberland's fundamentals look outstanding. But continuing concerns about Acetadote and a lack of game-changers in the pipeline means a catalyst is tough to ...

Cumberland Pharmaceuticals Inc. Annual cash flow by MarketWatch. View CPIX net cash flow, operating cash flow, operating expenses and cash dividends.